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Abstract
Background: Cervical Cancer (CC) has become a public health concern of alarming proportions in many
developing countries such as Mexico, particularly in low income sectors and marginalized regions. As such, an early
detection is a key medical factor in improving not only their population’s quality of life but also its life expectancy.
Interestingly, there has been an increase in the number of reports describing successful attempts at detecting
cancer cells in human tissues or fluids using trained (sniffer) dogs. The great odor detection threshold exhibited by
dogs is not unheard of. However, this represented a potential opportunity to develop an affordable, accessible, and
non-invasive method for detection of CC.
Methods: Using clicker training, a male beagle was trained to recognize CC odor. During training, fresh CC biopsies
were used as a reference point. Other samples used included cervical smears on glass slides and medical surgical
bandages used as intimate sanitary pads by CC patients. A double-blind procedure was exercised when testing the
beagle’s ability to discriminate CC from control samples.
Results: The beagle was proven able to detect CC-specific volatile organic compounds (VOC) contained in both
fresh cervical smear samples and adsorbent material samples. Beagle’s success rate at detecting and discriminating
CC and non-CC odors, as indicated by specificity and sensitivity values recorded during the experiment, stood at
an overall high (>90%). CC-related VOC in adsorbent materials were detectable after only eight hours of use by
CC patients.
Conclusion: Present data suggests different applications for VOC from the uterine cervix to be used in the
detection and diagnosis of CC. Furthermore, data supports the use of trained dogs as a viable, affordable, non-
invasive and, therefore, highly relevant alternative method for detection of CC lesions. Additional benefits of this
method include its quick turnaround time and ease of use while remaining highly accurate and robust.
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Background
Cervical cancer (CC) represents a serious public health
concern worldwide among the female cancer spectrum.
In Mexico, its incidence levels stand at an alarming
15.5% per year with a mortality rate of 12.8% [1].
Widely accepted in the scientific community, infection
by Human Papillomavirus (HPV) is the main risk factor
for CC development but its presence, however, is not
sufficient for malignant transformation. In fact, a broad
variety of co-factors and a significant number of molecu-
lar events exert influence in such process [2, 3]. Further-
more, the reprogramming of energy metabolism is now
part of the hallmarks of cancer [4], undoubtedly com-
prised of important biological capabilities acquired dur-
ing the multi-step development of human tumors and
constituting an organizing principle for rationalizing the
complexities of neoplastic disease.
Current standards for cancer diagnosis rely heavily on
biopsy. In the case of CC, the standard extends to cyto-
logical and colposcopy procedures in addition to early
detection of precursor lesions. With tests taking up to
1 month to return results, current diagnosis standards
for cancer present an area of opportunity, particularly
for developing countries and marginalized areas that face
more severe issues such as the lack of proper medical
and testing facilities.
Since the late 20th Century, reports of cancer detec-
tion by trained scent (sniffer) dogs have been on the rise,
using different biological fluids such as urine, breath,
blood, and stool with prompt results [5–8]. According to
a recent report by Horvath [9], the specific odor of car-
cinoma plays an important role in the diagnosis and dis-
ease monitoring of cancer. In this context, various
human cancers, such as breast, melanoma, lung, ovary,
gastric, and prostate, have been considered for their
evaluation by sniffer dogs as an accessible biological
sample (direct or indirectly) [5–17].
The present work had as a goal the introduction and
improvement of a non-invasive tool to aid in detection
of cervical cancer, to test detection of CC-associated
VOC by a sniffer dog, and testing different methods
(both invasive and non-invasive) of harboring such
compounds.
Methods
Research met all ethical guidelines and practices, as
overseen by the Comisión Nacional de Investigación
Científica (Scientific Research National Committee) at
the Instituto Mexicano del Seguro Social (Mexican Insti-
tute for Social Security, IMSS).
A total of 20 fresh biopsies, 50 CC smear samples, and
30 healthy cervical smears samples were employed in
this research. All biopsy samples were collected from pa-
tients who attended Brachytherapy Service at the
Oncology Hospital, CMN-SXXI-IMSS, in Mexico City.
Normal cervices without HPV infection or precancerous
lesions were also collected for use as control samples from
routine gynecological examination patients at the Colpos-
copy Clinic. Additionally, a total of 70 patients affected by
invasive CC used medical adsorbent surgical bandages as
intimate sanitary pads to be used as samples. Commercial
intimate feminine sanitary pads with nanomaterial that
absorbs odor and fluids and with added scent, such as
Aloe vera or chamomile were also admitted after approxi-
mately 8 h of use. Usage of surgical bandages by healthy
women lasted 1 h, 8 h, 12 h, or 24 h.
Inclusion criteria for women participating in the study
include: use of intimate vaginal scents and/or vaginal
douches, being on any diet, alcohol or drug consump-
tion, and age >20 years; women in their early or late
phase menstrual period; women using oral contracep-
tives; one woman with diabetes; women who smoke;
women with bacterial vaginosis; and three pregnant
women of 3, 5, and 7 months. The majority of women
resided in Mexico City, although others were from the
state of México (1 h distance by car), Taxco, Guerrero
(3 h distance by car), and Tuxtla Gutierrez, Chiapas
(1.5 h distance by plane). Female participants, therefore,
represent different ethnic groups from different environ-
ments with different lifestyles and diets which may have
included a variety of spices and meats. All patients par-
ticipating in this research provided prior approval and
signed an informed consent form. Control samples, on
the other hand, included, sink water, saline buffer, HPV
vaccine (Gardasil [virus-like particles, VLP] 1 μg), plas-
mid DNA cloning of different fragments of the HPV
genome, the CaSki cell line, aerosol tissue fixative, stem
cell extracts (commercial products), white blood cells
(WBC), red blood cells (RBC), earth/soil, exhaled breath,
and sweaty finger.
Biopsies were sectioned and paraffin embedded.
Hematoxylin and eosin (H&E) stained sections were
analyzed to confirm tumor presence of at least 50%
per sample, including squamous cervical carcinoma
and adenocarcinomas. The first scrape of smear sam-
ples was obtained using a cervical brush for routine
cytological examination while the remaining material
was deposited in 50 ml Falcon tube. First round of
H&E smears was always subjected to evaluation by a
pathologist to determine and confirm cytological sta-
tus. Because of the possibility of having mixed cell
types in biopsies, expectation was to get fewer
amounts of exfoliated cells.
All tests were carried out in a double-blind procedure.
The two canine handlers participating in the study were
experienced and present at all test times. They were re-
sponsible for recording results and did so wearing dis-
posable polyethylene gloves at all times, exchanging
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them for a clean pair every two samples to avoid sample
contamination.
Dog training, positive conditioning clicker method.
For the purpose of this research, one three-year-old
male beagle was trained to identify and discriminate CC
odor. To accomplish this, a 15-min training routine was
conducted every morning, 5 days a week. During
training, the beagle had his own cell to rest in, was
allowed to play with other dogs without restriction and
his regular diet composed of typical dog food remained
the same. The beagle had no previous scientific experi-
ence but had been formerly trained for drug detection,
however.
Two groups of artifacts were used during training tri-
als: 1) ten 20 cm cubic wood boxes with a 5 cm hole in
the upper side, and 2) ten steel cylindrical containers
measuring 15 cm of diameter and 30 cm high. The two
groups were used interchangeably, but only one group
would be used during a given trial. Artifacts were placed
on the floor and arranged in a circle and about 50 cm
apart from each other. Each artifact contained one sam-
ple. Samples were randomly arranged to include 9
healthy ones and 1 CC. Each trial comprised two runs.
During the first run, the beagle was directed by the han-
dlers to sniff all samples freely. The second time, the
dog was directed to move towards the CC sample to in-
struct him which one was to be considered his target
sample. This detection routine (Fig. 1) remained the
same throughout research. Upon accurate display of de-
sired behavior, handlers would indicate his success to
the beagle using traditional clicker training techniques
and then rewarded him with food. In this manner, the
beagle learned to identify the odor of a fresh CC biopsy
as the target sample and sit down in front of it to indi-
cate his findings. The target sample became a referential
marker for further experiments and considered as the
“CC-scent.”
Upon completion of the training program, the beagle
was presented with a new challenge: discrimination be-
tween healthy and cervical cancer smears. With the
intention of properly assessing detection probability, CC
cells were decreased in amount with different exposure
methods, replacing CC biopsies with cytological smears,
which contain a significantly lower amount of cells. Fi-
nally, the medical surgical bandages (with no added per-
fume scent) were introduced as samples during trials.
Afterwards, a new series of 270 new surgical bandages
were analyzed (group 1): 170 from healthy women as
controls, and 100 from patients with CC (some patients
with endometrial cancer were included in this group).
In order to avoid any pitfall molecule, present in the
hospital- or clinic-rooms, all surgical bandages were
used overnight in-home, and after that, each female sub-
ject deposited it into individual seal packaging bag and
carried-out to the hospital or clinic to collect them.
Under no circumstance were the bags opened in the
hospital-or clinic-rooms and were always cleaned before
use, to avoid any aromatic contamination.
False Alerts (FA) were called in and recorded every time
the beagle marked a “healthy” sample as the target in a
clear manner. Each of these occurrences was followed by
proper, random repositioning of the target sample before
running a new trial.
Data analysis
Sensitivity is the primary parameter for measuring the
dog’s success in marking a sample (bandage used by the
oncologic patient) as target. Specificity is used instead to
measure the dog’s performance in identifying patients
without the disease [18].
Fig. 1 Study design. The figure summed up the time used for training. It is expected that the medical adsorbent surgical bandage or pad could
harbor a range of 1 × 10^3–11 cells among other substances and molecules. The background in the narrows depicts tumor tissue (original
amplification, 100×) and cervical smear (original amplification, 400×), Hematoxylin and eosin (H&E)-stained
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Sensitivity and specificity values were calculated with
95% Confidence intervals (95%CI); positive and negative
prognostic values were calculated by using Epidat v3.1
software. The gold standard was the biopsy (for cervical
cancer sample) or cervical cytology (for healthy sub-
jects). Positive and negative predictive values were ad-
justed to the CC prevalence by using Bayes theorem.
Results
Training to smell the fresh CC biopsy
A vital challenge to this research was training the beagle
to identify CC’s volatile compounds. During his training,
he worked only with a variety of CC biopsies of epi-
dermoid and adenocarcinoma types. Healthy smears
were only introduced later. The beagle’s first three trials
exhibited various FAs. His training routine, explained
earlier, endured for 4 months before he was able to fully
and unequivocally identify the odor, showing no signs of
hesitation when pointing target samples. Only then were
cervical smears introduced into the sample pool, de-
creasing the amount cells both healthy and transformed
in magnitude by several orders.
The smears samples challenge
Smear samples, as it was to be expected, presented vagi-
nal mucus and cervical cells from oncological patients’
blood. Interestingly, when introduced into the sample
pool, only the first trial presented a FA. Again, only
when the beagle succeeded in fully and unequivocally
identifying the target sample as such were medical ad-
sorbent materials introduced into the sample pool.
The surgical bandages challenge
Like in smear samples, vaginal mucus and cervical cells
were both present in all medical adsorbent material sam-
ples. However, traces of urine and blood were also de-
tected. Surprisingly, neither represented an obstacle for
the beagle to identify target samples.
Flying solo, discerning CC scent volatile compounds
Research produced 873 test results from nearly 100 trials
just from 97 cervical cancer smears and 776 from
healthy women samples. Meanwhile, for surgical ban-
dages, 495 test results from nearly 60 trials just from 55
oncological patients and 440 from healthy subjects.
Table 1 illustrates results obtained from trials where
smears and adsorbent material samples were used. Sen-
sitivity registered from both sample types was of 92,78
and 96,36%, respectively; corresponding specificity values
stood at 99,1 and 99,55%; predictive values at 92,78 and
96,36%; and the negative predictive values at 99,1 and
99,55%. The false negative rate registered was notably
lower in the case of adsorbent material samples (Table 1),
suggesting this type of sample might be more efficient for
medical applications to identify CC odor. Unexpectedly,
the beagle displayed interest in all samples containing
endometrial cancer cells (n = 10), risking proper identifica-
tion of CC odor and suggesting similarities in their volatile
compounds. Commercial intimate feminine sanitary pads
with added scent also triggered a particular interest in the
beagle. Exhaustive analysis indicates the pad’s material
produced a false positive result. Hence, its inclusion as a
capture method has been discarded. On the other hand,
the beagle’s performance seemed unaltered by inert or
chemical materials in control samples like vaginal
douches, glass, cotton, lotions, cloned HPV DNA, the
VLP vaccine, or live material such as blood or cells. Sub-
jects’ places of origin and lifestyle conditions were not a
significant indicator in FA results. Regarding the group 1
of samples analyzed, no FAs were registered for control
samples while CC samples were marked correctly.
Discussion
Cervical Cancer is one of the most important health con-
cerns among women in Mexico [19]. This research and, as
such, the development of alternative methods for early
and prompt detection of CC, represents a huge medical
improvement for individuals and health institutions alike,
potentially refocusing research efforts to other areas. In
addition, it can provide great benefits to developing coun-
tries and marginalized regions exhibiting deficits in health
services and facilities, which explain partially the high inci-
dence of Cervical Cancer among their populations due to
their extremely low income and widespread taboos and
prejudices. Because of how damaging CC can be to female
populations in these countries, addressing this health
problem should be a priority.
Inspired to contribute to global medical communities’
efforts, our team suggests the use of medical adsorbent
surgical bandage as a fast, inexpensive, simple, safe, easy
to use, non-invasive tool for capturing CC volatile
Table 1 Sensitivity and specificity measurements for cervical scrapes or medical adsorbent surgical bandages detected by a dog in
patients with Cervical Cancer (CC)
Sensitivity (95% CI*) Specificity (95% CI) PPV (95% CI) NPV (95% CI) PPVα NPVα FN
Scrapes 92,78% (87,12–98,45) 99,1% (98,37–9,83) 92,78% (87,1–98,45) 99,1% (98,37–99,83) 93,95% 98,91% 7
Surgical bandages 96,36% (90,51–100) 99,55% (98,8–100) 96,36% (90,51–100) 99,55% (98,8–100) 97,00% 99,45% 2
*Confidence Interval, PPV Positive Predictive Value, NPV Negative Predictive Value, αPositive and negative predictive values were adjusted to the prevalence of
Cervical cancer (CC) in Mexico (13.1% according to GLOBOCAN Project, reference 19), FN False Negative
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compounds when used as a sanitary pad by patients. Its
ability to collect several of the body’s metabolites such as
scraped cells and mucus, urine drops, personal odor, sweat
and sebum, which can be used to detect molecules related
with cancer, in a manner that is acceptable for use by the
patient makes it a viable solution (Fig. 2).
Different methods for harboring CC odor were also ex-
plored in the development of a strategy to discriminate
between healthy and cancerous samples. Having as a
premise dog’s ability to learn to identify cancer odor as
specific organic compounds or “fingerprints,” our team
concluded CC biopsies harboring mostly transformed cells
(including other kinds of cells) represent the best starting
point for training a dog. The amount of cells per sample
supported our original theory that CC biopsies harbored
enough information for a dog to identify and learn cancer
odor. Furthermore, biopsies could harbor CC’s “finger-
print” without contaminant odors. Dog training proce-
dures like the one employed in this research have been
used before in successful detection of several cancer odors
[5, 8, 12], supporting our original theory and conclusion.
Our team was challenged with reducing the number of
cells from samples to measure any correlation between
the number of cells contained within a sample and a dog’s
ability to “pick up” the scent. Research results indicate
there is none. Moreover, the beagle employed in this
research displayed enormous ability in identifying CC
odor regardless of the number of cells contained in the
sample. Even more surprising, the beagle identified CC
odor specifically rather than the subject or patient, dis-
criminating and detecting specific CC samples. Research
data, ultimately, supports the impressive ultra-fine olfac-
tory system attributed to dogs [20, 21].
In present day, the scent of a number of diseases, includ-
ing cancer, can be detected through the use of lab methods
such as chromatography [8, 19–26]. There are great differ-
ences, however, between using chromatography and a dog,
having a detection threshold of parts per billion (ppb) and
parts per trillion (ppt) respectively [27]. Our research team
thinks that first screenings (presumptive and rapid pre-
screening) in isolated communities will become far more
accessible if carried out by a trained dog rather than by so-
phisticated equipment. Obviously, this is presented as an al-
ternative and caution is a must, as are additional studies on
the subject. In general, after CC detection during the first
screening, patients should be clinically evaluated. Our sug-
gested method allows for minimization of time, resources,
and money invested by the patient without sacrificing ac-
curacy or robustness in test results. Based in current studies
and data available, our research team suggests pad-based
detection to be used only as a first screening test.
Chromatography from surgical bandages validates the
presence of several volatile compounds in cervical cancer
(Fig. 3). However, cervico-vaginal odor results only partially
due to the cellular decomposition by microorganisms
present in this area. Eight hours of use of adsorbent material
produces a complex mixture of molecules from different
physio and/or pathological fluids, sweat, urine, etc. Because
of this, our research team considered that cancerous odor
could be masked or even completely imperceptible.
However, the beagle’s ability to identify CC odor seemed
unaffected. In fact, the beagle was able to recognize specific
Fig. 2 Medical adsorbent surgical bandages as “adsorber” of several human fluids for cancer detection. The pad could contain a mixture of cells
(epithelial healthy and sick cells) and certain other fluids potentiating the cancer odor emitted by the patient. Also presented is the detection of
mitochondrial DNA obtained from cells on the surface of the surgical bandage. Lane a) molecular weight marker 100 base pairs (bp) DNA ladder;
Lane b) DNA positive control; Lane c) negative control; Lane d) amplicon (150 bp) from control subject without cervical lesion, and Lane e) from
a Cervical cancer patient-affected (CC)
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substances related to cancer as memorized odors and even
detect CC-scent from different types of samples. In other
words, samples collected from both invasive and non-
invasive methods work for presenting “cervical cancerous
odor” to a trained sniffer dog.
Our findings are supported partially by a work in
which a vaginal self-sampling at home showed efficacy
and cost-effectiveness for HPV detection in CC screen-
ing [28]. Additionally, our team considers medical surgi-
cal bandages can become an environment-friendly tool
for detecting cancer odor in the near future.
Finally, the beagle displayed ability to identify samples
containing endometrial cancer. This could be explained
partially by the biological capabilities acquired during
multi-step development of the tumors [4] and that these
two gynecological tumors could share common volatile
compounds. The latter is supported by a report by Hor-
vath et al. (2008) which describes a dog trained to detect
ovarian cancer was also able to detect other types of
cancer, ultimately resulting in a potential drop in specifi-
city values [9]. Our research team is currently perform-
ing additional studies to provide clarity to the subject. If
Fig. 3 Comparison of gas chromatograph-mass spectrometry (volatile organic compounds) of adsorbent bandages used by healthy and Cervical
Cancer-affected women. After usage of the adsorbent pads during 8 hours, these were subjected to an analysis by gas chromatography-mass
spectrometry. The compounds were obtained by using the experimental conditions: hexane at 4°C with DB-column of 1.25 mm×60 m×0.25-μm
and Helium gas carrier by employing Agilent gas chromatography-mass spectrometry equipment. The upper chromatogram represents a healthy
woman, and the lower chromatogram from a Cervical Cancer-affected patient. The x-axis represents the time retention in minutes, while the
y-axis the curve area. The graph is showing an example of mass spectrum of the following organic compounds: Oxirane; 2-methyl-3-propyl-trans;
5 H Tetrazol-5-amine; Eicosane and Dibutyl phthalate (DP) presented in the healthy women (Healthy chromatogram), while the 3 Ethyl-3-methyl
heptane; 3,3 Dimethyl-1 [2 carboxyphenyl] triazine; and DP in the cancer patient (Cervical Cancer chromatogram), where a clear difference in
DP concentrations between women was observed (vertical red rectangle). Chemical structure of the organic compounds is also showed
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our theory is correct, the applications for surgical ban-
dages as non-invasive tool could broaden to include the
detection of endometrial cancer and other tumors like
ovary and breast cancers. Very recently, we have deter-
mined that sanitary pads are also able to collect VOC
related to ovary cancer samples, as well as from breast
samples. We are also employing a mask to collect vola-
tile compounds from exhaled breath for several cancers
of the upper aero-digestive tract (data not shown).
Conclusions
Our research team is convinced that the trainer-dog
partnership and the use of surgical bandages as the
means to collect samples, both described in this re-
search, are viable alternative tools for exploring and de-
tecting cervical cancerous odor, even more when paired
together. The benefits of these tools include inexpensive-
ness, accuracy, ease of use, non-invasiveness, and high
sensitivity and specificity. Applications for these tools
extend to providing much needed medical attention for
women from cultural backgrounds imposing several pro-
hibitions, deep-rooted cultural taboos, or lack of health
coverage. Additionally, the use of a trained dog for
screening facilitates prevention campaigns in areas of
difficult access, saving money, labor, and the loss of lives
due to late diagnosis. Finally, surgical bandages could
also be used to detect endometrial cancer and potentially
other tumors like ovary and breast cancer.
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